Retatrutide helped trial participants lose up to 28.7% of their body weight, but experts warn about excessive weight loss.

Many injectable peptides are unregulated and have not been reviewed for safety by the FDA. Users have reported side effects such as injection site reactions, fatigue, headaches, and gastrointestinal ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." By now, your news feed, your dinner table conversations, and your doctor’s office have been flooded with ...

Dec 17 (Reuters) - The U.S. Food and Drug Administration said on Tuesday it has sent warning letters to four companies for selling unapproved versions of GLP-1 drugs including semaglutide and ...

Eli Lilly’s experimental weight-loss drug retatrutide led to an average weight reduction of up to 28.7%—more than 71 pounds—in adults with obesity or overweight and knee osteoarthritis. Participants ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Retatrutide at its highest dose resolved steatosis in ...